Liver toxicity associated with tuberculosis chemotherapy in the REMoxTB study
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Liver toxicity associated with tuberculosis chemotherapy in the REMoxTB study
Authors
Keywords
Tuberculosis, Hepatotoxicity, Drug-induced liver injury, Treatment monitoring
Journal
BMC Medicine
Volume 16, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-04-04
DOI
10.1186/s12916-018-1033-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mechanisms of adaptation and progression in idiosyncratic drug induced liver injury, clinical implications
- (2015) Lily Dara et al. LIVER INTERNATIONAL
- Hepatotoxicity of anti-tuberculosis chemotherapy in patients with liver cirrhosis
- (2014) H. J. Shin et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Monitoring liver function among patients who initiated anti-tuberculosis drugs in Taiwan, 2000–2011
- (2014) H-C. Chou et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis
- (2014) Stephen H. Gillespie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluation of Patterns of Liver Toxicity in Patients on Antiretroviral and Anti-Tuberculosis Drugs: A Prospective Four Arm Observational Study in Ethiopian Patients
- (2014) Getnet Yimer et al. PLoS One
- Association of NAT2, GST and CYP2E1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity
- (2014) Neha Singla et al. TUBERCULOSIS
- Hepatotoxicity due to first-line anti-tuberculosis drugs: a five-year experience in a Taiwan medical centre
- (2013) C-C. Shu et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Anti-Tuberculosis Drug Induced Hepatotoxicity among TB/HIV Co-Infected Patients at Jimma University Hospital, Ethiopia: Nested Case-Control Study
- (2013) Alima Hassen Ali et al. PLoS One
- Monitoring for Tuberculosis Drug Hepatotoxicity: Moving from Opinion to Evidence
- (2012) Jussi J. Saukkonen et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Effect of scheduled monitoring of liver function during anti-Tuberculosis treatment in a retrospective cohort in China
- (2012) Shanshan Wu et al. BMC PUBLIC HEALTH
- CYP2E1 RsaI/PstI polymorphism and risk of anti-tuberculosis drug-induced liver injury: a meta-analysis [Review article]
- (2012) R. Deng et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Sex, ethnicity, and slow acetylator profile are the major causes of hepatotoxicity induced by antituberculosis drugs
- (2012) Julián G Chamorro et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Slow N-acetyltransferase 2 genotype contributes to anti-tuberculosis drug-induced hepatotoxicity: a meta-analysis
- (2012) Haijian Du et al. MOLECULAR BIOLOGY REPORTS
- A Comparison between Two Strategies for Monitoring Hepatic Function during Antituberculous Therapy
- (2011) Aran Singanayagam et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Case Definition and Phenotype Standardization in Drug-Induced Liver Injury
- (2011) G P Aithal et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Antituberculosis therapy-induced acute liver failure: Magnitude, profile, prognosis, and predictors of outcome
- (2010) Ramesh Kumar et al. HEPATOLOGY
- Antituberculosis drug-induced hepatotoxicity: Concise up-to-date review
- (2007) Alma Tostmann et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started